Literature DB >> 21844390

Multiple CD4+ T cell subsets produce immunomodulatory IL-10 during respiratory syncytial virus infection.

Kayla A Weiss1, Allison F Christiaansen, Ross B Fulton, David K Meyerholz, Steven M Varga.   

Abstract

The host immune response is believed to contribute to the severity of pulmonary disease induced by acute respiratory syncytial virus (RSV) infection. Because RSV-induced pulmonary disease is associated with immunopathology, we evaluated the role of IL-10 in modulating the RSV-specific immune response. We found that IL-10 protein levels in the lung were increased following acute RSV infection, with maximum production corresponding to the peak of the virus-specific T cell response. The majority of IL-10-producing cells in the lung during acute RSV infection were CD4(+) T cells. The IL-10-producing CD4(+) T cells included Foxp3(+) regulatory T cells, Foxp3(-) CD4(+) T cells that coproduce IFN-γ, and Foxp3(-) CD4(+) T cells that do not coproduce IFN-γ. RSV infection of IL-10-deficient mice resulted in more severe disease, as measured by increased weight loss and airway resistance, as compared with control mice. We also observed an increase in the magnitude of the RSV-induced CD8(+) and CD4(+) T cell response that correlated with increased disease severity in the absence of IL-10 or following IL-10R blockade. Interestingly, IL-10R blockade during acute RSV infection altered CD4(+) T cell subset distribution, resulting in a significant increase in IL-17A-producing CD4(+) T cells and a concomitant decrease in Foxp3(+) regulatory T cells. These results demonstrate that IL-10 plays a critical role in modulating the adaptive immune response to RSV by limiting T-cell-mediated pulmonary inflammation and injury.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21844390      PMCID: PMC3304096          DOI: 10.4049/jimmunol.1100764

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  68 in total

1.  Identification and functional characterization of a second chain of the interleukin-10 receptor complex.

Authors:  S V Kotenko; C D Krause; L S Izotova; B P Pollack; W Wu; S Pestka
Journal:  EMBO J       Date:  1997-10-01       Impact factor: 11.598

Review 2.  Interleukin-10: potential benefits and possible risks in clinical infectious diseases.

Authors:  S M Opal; J C Wherry; P Grint
Journal:  Clin Infect Dis       Date:  1998-12       Impact factor: 9.079

3.  B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10.

Authors:  L Schandené; C Alonso-Vega; F Willems; C Gérard; A Delvaux; T Velu; R Devos; M de Boer; M Goldman
Journal:  J Immunol       Date:  1994-05-01       Impact factor: 5.422

4.  Identification of a T cell subset capable of both IFN-gamma and IL-10 secretion in patients with chronic Borrelia burgdorferi infection.

Authors:  A Pohl-Koppe; K E Balashov; A C Steere; E L Logigian; D A Hafler
Journal:  J Immunol       Date:  1998-02-15       Impact factor: 5.422

5.  Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography.

Authors:  E Hamelmann; J Schwarze; K Takeda; A Oshiba; G L Larsen; C G Irvin; E W Gelfand
Journal:  Am J Respir Crit Care Med       Date:  1997-09       Impact factor: 21.405

6.  IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages.

Authors:  P Allavena; L Piemonti; D Longoni; S Bernasconi; A Stoppacciaro; L Ruco; A Mantovani
Journal:  Eur J Immunol       Date:  1998-01       Impact factor: 5.532

7.  Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses.

Authors:  D J Berg; N Davidson; R Kühn; W Müller; S Menon; G Holland; L Thompson-Snipes; M W Leach; D Rennick
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

8.  Characterization of interleukin-10 receptors on human and mouse cells.

Authors:  J C Tan; S R Indelicato; S K Narula; P J Zavodny; C C Chou
Journal:  J Biol Chem       Date:  1993-10-05       Impact factor: 5.157

9.  Interleukin-10-deficient mice develop chronic enterocolitis.

Authors:  R Kühn; J Löhler; D Rennick; K Rajewsky; W Müller
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

10.  Expression cloning and characterization of a human IL-10 receptor.

Authors:  Y Liu; S H Wei; A S Ho; R de Waal Malefyt; K W Moore
Journal:  J Immunol       Date:  1994-02-15       Impact factor: 5.422

View more
  61 in total

1.  Interleukin 10 modulation of pathogenic Th17 cells during fatal alphavirus encephalomyelitis.

Authors:  Kirsten A Kulcsar; Victoria K Baxter; Ivorlyne P Greene; Diane E Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-31       Impact factor: 11.205

2.  Infant Viral Respiratory Infection Nasal Immune-Response Patterns and Their Association with Subsequent Childhood Recurrent Wheeze.

Authors:  Kedir N Turi; Jyoti Shankar; Larry J Anderson; Devi Rajan; Kelsey Gaston; Tebeb Gebretsadik; Suman R Das; Cosby Stone; Emma K Larkin; Christian Rosas-Salazar; Steven M Brunwasser; Martin L Moore; R Stokes Peebles; Tina V Hartert
Journal:  Am J Respir Crit Care Med       Date:  2018-10-15       Impact factor: 21.405

3.  Altered Treg and cytokine responses in RSV-infected infants.

Authors:  Allison F Christiaansen; Muhammad A Syed; Patrick P Ten Eyck; Stacey M Hartwig; Lakshmi Durairaj; Sameer S Kamath; Steven M Varga
Journal:  Pediatr Res       Date:  2016-06-21       Impact factor: 3.756

Review 4.  Approaches to Evaluate Lung Inflammation in Translational Research.

Authors:  David K Meyerholz; Jessica C Sieren; Amanda P Beck; Heather A Flaherty
Journal:  Vet Pathol       Date:  2017-08-16       Impact factor: 2.221

5.  Co-immunization with virus-like particle and DNA vaccines induces protection against respiratory syncytial virus infection and bronchiolitis.

Authors:  Hye Suk Hwang; Young-Man Kwon; Jong Seok Lee; Si-Eun Yoo; Yu-Na Lee; Eun-Ju Ko; Min-Chul Kim; Min-Kyoung Cho; Young-Tae Lee; Yu-Jin Jung; Ji-Yun Lee; Jian-Dong Li; Sang-Moo Kang
Journal:  Antiviral Res       Date:  2014-08-07       Impact factor: 5.970

6.  NKG2D Regulation of Lung Pathology and Dendritic Cell Function Following Respiratory Syncytial Virus Infection.

Authors:  Huan Liu; Andrew R Osterburg; Jennifer Flury; Shuo Huang; Francis X McCormack; Stephania A Cormier; Michael T Borchers
Journal:  J Infect Dis       Date:  2018-10-20       Impact factor: 5.226

7.  PC61 (anti-CD25) treatment inhibits influenza A virus-expanded regulatory T cells and severe lung pathology during a subsequent heterologous lymphocytic choriomeningitis virus infection.

Authors:  Anke R M Kraft; Myriam F Wlodarczyk; Laurie L Kenney; Liisa K Selin
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

8.  Maternal antibodies by passive immunization with formalin inactivated respiratory syncytial virus confer protection without vaccine-enhanced disease.

Authors:  Young-Man Kwon; Hye Suk Hwang; Jong Seok Lee; Eun-Ju Ko; Si-Eun Yoo; Min-Chul Kim; Yu-Na Lee; Ki-Hye Kim; Jae-Min Song; Sujin Lee; Martin L Moore; Sang-Moo Kang
Journal:  Antiviral Res       Date:  2014-01-23       Impact factor: 5.970

9.  Prophylaxis with a respiratory syncytial virus (RSV) anti-G protein monoclonal antibody shifts the adaptive immune response to RSV rA2-line19F infection from Th2 to Th1 in BALB/c mice.

Authors:  Seyhan Boyoglu-Barnum; Tatiana Chirkova; Sean O Todd; Thomas R Barnum; Kelsey A Gaston; Patricia Jorquera; Lia M Haynes; Ralph A Tripp; Martin L Moore; Larry J Anderson
Journal:  J Virol       Date:  2014-07-02       Impact factor: 5.103

10.  Neonatal respiratory syncytial virus infection has an effect on lung inflammation and the CD4(+) CD25(+) T cell subpopulation during ovalbumin sensitization in adult mice.

Authors:  A Comas-García; C P López-Pacheco; E A García-Zepeda; G Soldevila; P Ramos-Martínez; J Ramos-Castañeda
Journal:  Clin Exp Immunol       Date:  2016-05-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.